Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Determining eligibility for tax loss harvesting with dividend ETFs involves understanding lot identification, wash sale rules, and cost basis calculations.
15,468 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Tiny changes can add up fast. This guide shares 16 practical steps you can start today to boost savings, cut debt, an...
IAMGOLD has rocketed higher over the past year, with a 273% gain in 12 months. The driving force is not just gold's r...
Stocks drift lower on March 10, 2026 as oil prices slide, muting tech gains. This stock market live march update expl...
Tech stocks lead early gains as oil eases and AI developments grab attention. The live Nasdaq Composite shows tech st...
Oil markets surged as geopolitical tensions flared, with brent crude briefly topping the $119 mark. This article outl...
The S&P 500 faced renewed selling on March 24, 2026, as traders weighed higher yields and mixed earnings. The stock m...
A federal judge blocked the Trump administration from labeling Anthropic a supply chain risk, calling the move a poss...
A hedge fund manager publicly admits that his temperament blocks Buffett-style value investing. The admission highlig...
Investors are watching the CLARITY Act as the Senate considers the bill this week. Traders say crypto markets massive...
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...
Investors are weighing a bold ripple (xrp) price prediction as regulatory chatter and on-chain expansion add fuel to ...